Melanoma: Are we there yet?
Donald L. Morton, MD … A living legend in surgical oncology
Evidence-based treatment of early-stage melanoma
Ultrasound assessment of lymph nodes in the management of early-stage melanoma¶
Role of selective sentinel lymph node dissection in head and neck melanoma
Clinically relevant information from sentinel lymph node biopsies of melanoma patients¶
Update on the melanoma staging system: The importance of sentinel node staging and primary tumor mitotic rate¶
Neoadjuvant therapy for high-risk bulky regional melanoma
Local and intralesional therapy of in-transit melanoma metastases
Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion
Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma
Rationale for complete metastasectomy in patients with stage IV metastatic melanoma
Systemic treatment of metastatic melanoma: New approaches
Current and planned multicenter trials for patients with primary or metastatic melanoma¶
Prognostic molecular biomarkers for cutaneous malignant melanoma¶
Community melanoma research: From start up to follow up